N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
Eli Lilly and Company
National Cancer Institute (NCI)
University of Regensburg
Memorial Sloan Kettering Cancer Center
New Approaches to Neuroblastoma Therapy Consortium
St. Jude Children's Research Hospital
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Children's Oncology Group
National Cancer Institute (NCI)
Duke University
Duke University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)